Expression of a multidrug resistance gene in blast crisis of chronic myelogenous leukemia.

No abstract is available for this paper.

• Publication year

  1989

• Venue

  Cancer Communications

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.3727/095535489820875354PMID 2639725
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• No references are available for this paper.

• Doxorubicin and other anthracyclines in cancers: Activity, chemoresistance and its overcoming.

  2023cites this paper
• Generation of Two Paclitaxel-Resistant High-Grade Serous Carcinoma Cell Lines With Increased Expression of P-Glycoprotein

  2021cites this paper
• Taxanes in cancer treatment: Activity, chemoresistance and its overcoming.

  2021cites this paper
• Not only P-glycoprotein: Amplification of the ABCB1-containing chromosome region 7q21 confers multidrug resistance upon cancer cells by coordinated overexpression of an assortment of resistance-related proteins.

  2017cites this paper
• Thiosemicarbazones Target Multiple Resistance Pathways in Cancer

  2016cites this paper
• methotrexate in patients with acute lymphocytic leukemia Defective transport as a mechanism of acquired resistance to

  2011cites this paper
• Therapeutic efficacy of combination of antitumor agent with AHC-52 against multidrug-resistant cells in the intravenously inoculated P388 leukemia model

  2004cites this paper
• Multidrug Resistance ( mdr l ) Gene Expression in Adult Acute Leukemias : Correlations With Treatment Outcome and In Vitro Drug Sensitivity

  2003cites this paper
• Novel therapies for chronic myelogenous leukemia.

  2001cites this paper
• Increase in tumor GADD153 mRNA level following treatment correlates with response to paclitaxel

  2000cites this paper
• Multidrug resistance in leukemias and its reversal.

  1996cites this paper
• The MDR phenotype in hematologic malignancies: prognostic relevance and future perspectives

  1996cites this paper
• What Does Multidrug Resistance (MDR) Expression Mean in the Clinic?

  1996cites this paper
• P-glycoprotein: clinical significance and methods of analysis.

  1995cites this paper
• 12-O-tetradecanoylphorbol-13-acetate activation of the MDR1 promoter is mediated by EGR1

  1995cites this paper
• P-Glycoproteins in Tumors

  1995cites this paper
• P-Glycoprotein: Clinical Significance and Methods of Analysis

  1995cites this paper
• Expression of MDR-1/P-glycoprotein in childhood acute megakaryoblastic leukemia cells.

  1995cites this paper
• In vitro drug sensitivity of leukemic progenitors and P‐glycoprotein expression in adult acute myeloid leukemia: correlation with induction treatment outcome

  1995cites this paper
• Multidrug resistance in the laboratory and clinic.

  1994cites this paper
• MDR1 gene expression in chronic lymphocytic leukemia.

  1994cites this paper
• MDRl Gene Expression in Chronic Lymphocytic Leukemia

  1994cites this paper
• Molecular basis of Ph+ leukemia and finding the way to treat them

  1994cites this paper
• Colchicine-induced multiple drug resistance in C-6 glioma

  1994cites this paper
• Multidrug resistance in leukemia.

  1993cites this paper
• MDR1 gene expression in primary colorectal carcinomas.

  1993cites this paper
• P-glycoprotein expression in normal and reactive bone marrows.

  1993cites this paper
• Inhibition of the multidrug resistance efflux pump.

  1993cites this paper
• MDR1 RNA expression as a prognostic factor in acute myeloid leukemia: an update.

  1993cites this paper
• How cancer cells evade chemotherapy: sixteenth Richard and Hinda Rosenthal Foundation Award Lecture.

  1993cites this paper
• Function and regulation of the human multidrug resistance gene.

  1993cites this paper
• MDR1 gene expression and its clinical relevance in primary gastric carcinomas

  1993cites this paper
• Multidrug resistant gene 1 product in human T cell subsets: role of protein kinase C isoforms and regulation by cyclosporin A.

  1992cites this paper
• Multidrug resistance in human cancer.

  1992cites this paper
• Expression of the MDR1 Gene and Treatment Outcome in Acute Nonlymphocytic Leukemia

  1992cites this paper
• Multidrug resistance in leukaemia.

  1992cites this paper
• Defective transport as a mechanism of acquired resistance to methotrexate in patients with acute lymphocytic leukemia

  1992cites this paper
• The role of the MDR1 (P-glycoprotein) gene in multidrug resistance in vitro and in vivo.

  1992cites this paper
• Defective transport as a mechanism of acquired resistance to methotrexate in patients with acute lymphocytic leukemia.

  1992cites this paper
• Expression of the MDR1 gene in human cancers.

  1991cites this paper
• MDR1 gene expression and prognostic factors in primary breast carcinomas.

  1991cites this paper
• Expression and activity of P-glycoprotein, a multidrug efflux pump, in human hematopoietic stem cells.

  1991cites this paper
• Multidrug resistance from the clinical point of view.

  1991cites this paper
• Papers MDRl Gene Expression and Prognostic Factors in Primary Breast Carcinomas

  1991cites this paper
• Expression of the Multidrug Resistance Gene in Human Cancer

  1991cites this paper
• Multidrug resistance (mdr) genes in human cancer.

  1991cites this paper
• Multidrug resistance (mdr1) gene expression in adult acute leukemias: correlations with treatment outcome and in vitro drug sensitivity.

  1991cites this paper
• Reversal of multi‐drug resistance in human KB cell lines by structural analogs of verapamil

  1990cites this paper